358 related articles for article (PubMed ID: 26993784)
41. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
[TBL] [Abstract][Full Text] [Related]
42. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
43. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.
Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL
Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification.
Arici A; Ozgur T; Ugras N; Yalcinkaya U
Indian J Cancer; 2013; 50(3):164-9. PubMed ID: 24061453
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
46. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
[TBL] [Abstract][Full Text] [Related]
47. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
[TBL] [Abstract][Full Text] [Related]
48. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
49. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
50. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
Thway K; Wang J; Swansbury J; Min T; Fisher C
Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
[TBL] [Abstract][Full Text] [Related]
51. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
Tajima S; Koda K
Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
[TBL] [Abstract][Full Text] [Related]
52. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
53. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
[TBL] [Abstract][Full Text] [Related]
54. Tyrosine Kinase Receptor Expression in Canine Liposarcoma.
Avallone G; Pellegrino V; Roccabianca P; Lepri E; Crippa L; Beha G; De Tolla L; Sarli G
Vet Pathol; 2017 Mar; 54(2):212-217. PubMed ID: 27698080
[TBL] [Abstract][Full Text] [Related]
55. Well-differentiated liposarcoma associated with benign lipoma.
Hatano H; Morita T; Ogose A; Hotta T; Kobayashi H; Honma K
Anticancer Res; 2004; 24(2C):1039-44. PubMed ID: 15154619
[TBL] [Abstract][Full Text] [Related]
56. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
Inyang A; Thomas DG; Jorns J
Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
[TBL] [Abstract][Full Text] [Related]
57. Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas.
Laroche-Clary A; Chaire V; Algeo MP; Derieppe MA; Loarer FL; Italiano A
J Hematol Oncol; 2017 Jun; 10(1):123. PubMed ID: 28629371
[TBL] [Abstract][Full Text] [Related]
58. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
[TBL] [Abstract][Full Text] [Related]
59. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
[No Abstract] [Full Text] [Related]
60. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
